São Paulo - Delayed Quote BRL

Empreendimentos Pague Menos S.A. (PGMN3.SA)

Compare
3.3000 +0.1000 (+3.12%)
At close: November 22 at 6:07 PM GMT-3
Loading Chart for PGMN3.SA
DELL
  • Previous Close 3.2000
  • Open 3.2500
  • Bid 3.3100 x --
  • Ask 3.3200 x --
  • Day's Range 3.1800 - 3.3500
  • 52 Week Range 2.1600 - 3.9706
  • Volume 1,188,600
  • Avg. Volume 753,820
  • Market Cap (intraday) 1.897B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 9.71
  • EPS (TTM) 0.3400
  • Earnings Date Nov 4, 2024
  • Forward Dividend & Yield 0.30 (8.96%)
  • Ex-Dividend Date Jan 29, 2024
  • 1y Target Est 3.85

Empreendimentos Pague Menos S.A. operates a chain of pharmacies in Brazil. The company offers medicines and health care products in the areas of paediatrics, oncology, psychiatry, urology, orthopedics, dermatology, contraception, pediatric endocrinology, assisted reproduction, geriatric, gastrointestinal and hepatic, pain, fever, and inflammation, diabetes, and endocrinology. It also provides personal care and beauty products, including deodorant, intimate care, and oral hygiene, as well as foot, hair, face, and hand care products; dermo-cosmetics; and repellent, diaper, cloth, and food products, as well as other accessories for moms and babies. In addition, the company offers clothing and accessories, supplements, first aid, food and drink, utilities, and others; and cereals, fibers, vitamins and minerals, first aid, and herbal medicines and natural products. Empreendimentos Pague Menos S.A. was incorporated in 1981 and is headquartered in Fortaleza, Brazil.

www.paguemenos.com.br

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PGMN3.SA

View More

Performance Overview: PGMN3.SA

Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PGMN3.SA
7.66%
IBOVESPA
3.77%

1-Year Return

PGMN3.SA
3.30%
IBOVESPA
2.80%

3-Year Return

PGMN3.SA
54.92%
IBOVESPA
25.32%

5-Year Return

PGMN3.SA
68.14%
IBOVESPA
28.20%

Compare To: PGMN3.SA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PGMN3.SA

View More

Valuation Measures

Annual
As of 11/22/2024
  • Market Cap

    1.90B

  • Enterprise Value

    5.25B

  • Trailing P/E

    9.71

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.15

  • Price/Book (mrq)

    0.71

  • Enterprise Value/Revenue

    0.43

  • Enterprise Value/EBITDA

    5.58

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.32%

  • Return on Assets (ttm)

    3.93%

  • Return on Equity (ttm)

    6.24%

  • Revenue (ttm)

    12.16B

  • Net Income Avi to Common (ttm)

    160.46M

  • Diluted EPS (ttm)

    0.3400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    169.6M

  • Total Debt/Equity (mrq)

    131.90%

  • Levered Free Cash Flow (ttm)

    234.34M

Research Analysis: PGMN3.SA

View More

Company Insights: PGMN3.SA

Research Reports: PGMN3.SA

View More

People Also Watch